CD133+ HNSCC cells exhibited higher levels of p-Src and concurrently displayed properties of mesenchymal cells, such as lower expression of E-cadherin and higher expression of vimentin, fibronectin, and transcription factors OCT4 and NANOG [164]. The gene discussed is NANOG; the disease is head and neck squamous cell carcinoma.